MedPath
FDA Approval

Itraconazole

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 27, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Itraconazole(100 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

COHANCE LIFESCIENCES LIMITED

Par Pharmaceutical, Inc.

677637710

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Itraconazole

Product Details

NDC Product Code
49884-239
Application Number
ANDA205724
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 12, 2023
Code: 304NUG5GF4Class: ACTIBQuantity: 100 mg in 1 1
HYPROMELLOSE 2910 (5 MPA.S)Inactive
Code: R75537T0T4Class: IACT
SUCROSEInactive
Code: C151H8M554Class: IACT
POLYETHYLENE GLYCOL 20000Inactive
Code: 5WKN5KL2O8Class: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
GELATINInactive
Code: 2G86QN327LClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357Class: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
SHELLACInactive
Code: 46N107B71OClass: IACT
© Copyright 2025. All Rights Reserved by MedPath